Dilon Diagnostics, a manufacturer and supplier of high-resolution molecular imaging systems, has received ISO 13485 certification.
Dilon claimed that its Dilon 6800 Gamma Camera is a high-resolution, small field-of-view gamma camera optimized to perform Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging procedure that aids in the effective management of suspicious and difficult-to-interpret breast cases.
The Dilon 6800 captures vital information by viewing the metabolic activity in the breast, it can identify lesions independent of tissue density and is capable of duplicating standard mammographic views. In addition the Dilon GammaLoc system, an accessory to the Dilon 6800, is the FDA-cleared localization device that enables gamma-guided, minimally invasive needle biopsy of suspicious lesions identified with BSGI.
Dilon’s recent distribution agreement with Philips allows it to sell and support its products in European and key Middle Eastern markets. The partnership demonstrates the endorsement of MBI/BSGI and its continued commitment to deliver the most advanced women’s health solutions worldwide.
Dilon Diagnostics, a brand of Dilon Technologies, has been bringing new medical imaging products to market. Dilon’s product, the Dilon 6800, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake.